167 related articles for article (PubMed ID: 33112058)
1. STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression.
Makitani K; Ogo N; Asai A
Physiol Rep; 2020 Oct; 8(20):e14627. PubMed ID: 33112058
[TBL] [Abstract][Full Text] [Related]
2. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
3. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
4. Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling.
Li Y; Guo F; Huang R; Ma L; Fu P
Int Immunopharmacol; 2021 Feb; 91():107279. PubMed ID: 33340783
[TBL] [Abstract][Full Text] [Related]
5. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease.
Pan J; Shi M; Guo F; Ma L; Fu P
Life Sci; 2021 Nov; 285():119946. PubMed ID: 34516993
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D
Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810
[TBL] [Abstract][Full Text] [Related]
8. C-X-C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β-catenin pathway.
Liu Y; Feng Q; Miao J; Wu Q; Zhou S; Shen W; Feng Y; Hou FF; Liu Y; Zhou L
J Cell Mol Med; 2020 Apr; 24(7):3837-3855. PubMed ID: 32119183
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.
Eis V; Luckow B; Vielhauer V; Siveke JT; Linde Y; Segerer S; Perez De Lema G; Cohen CD; Kretzler M; Mack M; Horuk R; Murphy PM; Gao JL; Hudkins KL; Alpers CE; Gröne HJ; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2004 Feb; 15(2):337-47. PubMed ID: 14747380
[TBL] [Abstract][Full Text] [Related]
11. Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway.
Qin T; Wu Y; Liu T; Wu L
BMC Complement Med Ther; 2021 Jan; 21(1):12. PubMed ID: 33407391
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.
Matsui F; Babitz SK; Rhee A; Hile KL; Zhang H; Meldrum KK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F25-F32. PubMed ID: 27760767
[TBL] [Abstract][Full Text] [Related]
13. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
14. SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.
Chen LH; Advani SL; Thai K; Kabir MG; Sood MM; Gibson IW; Yuen DA; Connelly KA; Marsden PA; Kelly DJ; Gilbert RE; Advani A
PLoS One; 2014; 9(3):e92227. PubMed ID: 24637920
[TBL] [Abstract][Full Text] [Related]
15. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
17. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
[No Abstract] [Full Text] [Related]
18. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
[TBL] [Abstract][Full Text] [Related]
19. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
Lu S; Fan HW; Li K; Fan XD
Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
